CAS: 1346133-08-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | LY-2795050 REF: IN-DA009CCVCAS: 1346133-08-1 | 95% | To inquire | Mon 21 Apr 25 |
 | LY2795050 REF: 54-BUP04875CAS: 1346133-08-1 | 97.77% | 452.00 €~2,182.00 € | Mon 21 Apr 25 |
 | LY2795050 REF: TM-TQ0091CAS: 1346133-08-1 | 97.77% | To inquire | Fri 25 Apr 25 |
 | LY2795050 REF: 3D-WDC13308CAS: 1346133-08-1 | Min. 95% | 331.00 €~1,600.00 € | Fri 30 May 25 |
Ref: IN-DA009CCV
| 1mg | 131.00 € | ||
| 2mg | 157.00 € | ||
| 5mg | 179.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
Ref: 54-BUP04875
| 25mg | 452.00 € | ||
| 100mg | 1,185.00 € | ||
| 200mg | 2,182.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
LY2795050
CAS:1346133-08-1
LY2795050 is a novel specific κ-Opioid Receptor antagonist (IC50: 0.72 nM).
Formula:
C23H22ClN3O2
Purity:
97.77%
Color and Shape:
Solid
Molecular weight:
407.89
Ref: TM-TQ0091
| 1mg | 52.00 € | ||
| 2mg | 74.00 € | ||
| 5mg | 116.00 € | ||
| 10mg | 180.00 € | ||
| 25mg | 298.00 € | ||
| 50mg | To inquire | ||
| 1mL*10mM (DMSO) | 127.00 € |
Estimated delivery in United States, on Friday 25 Apr 2025
LY2795050
CAS:1346133-08-1
Please enquire for more information about LY2795050 including the price, delivery time and more detailed …
Formula:
C23H22ClN3O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
407.89 g/mol
Ref: 3D-WDC13308
| 1mg | 331.00 € | ||
| 5mg | 420.00 € | ||
| 10mg | 598.00 € | ||
| 25mg | 1,000.00 € | ||
| 50mg | 1,600.00 € |
Estimated delivery in United States, on Friday 30 May 2025
